A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus
Vascular Health and Risk Management · 2024
DOI: 10.2147/vhrm.s461505 ↗Kurz gefasst
Fallbericht in der Zeitschrift Vascular Health and Risk Management, 2024. Verfasst von Nan Dang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Propranolol, Sarcoma, Kaposi, Sirolimus, Hemangioendothelioma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
- Children's Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
ORCID-Profile: Nan Dang
Zitieren
APA
Dang, N., & Ren, Y. (2024). A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.s461505
Vancouver
Dang N, Ren Y. A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus. Vascular Health and Risk Management. 2024. doi:10.2147/vhrm.s461505
BibTeX
@article{Dang2024,
author = {Dang, Nan and Ren, Yunqing},
title = {A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus},
journal = {Vascular Health and Risk Management},
year = {2024},
doi = {10.2147/vhrm.s461505}
}
EUVIMED